Drug Trial Radar · NCT04949633
Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening
Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,494
Planned (sponsor's estimate)
Start
Sep 28, 2021
Primary completion
Sep 2027
Study completion Nov 2027
Sponsor
- Lead sponsor
- University Hospital, ToursAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 2, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Twenty-two percent of deliveries in France are induced. In cases where labor is induced and cervix is unfavorable, cervical ripening prior oxytocin administration is advised in order to reduce the risk of cesarean delivery. Cervical ripening agents, pharmacological (prostaglandins) or mechanical are administered during 24 hours. After 24 hours, most women will be either delivered or in labor but 25% of women will require further induction of labor. For 16% of women who undergo cervical ripening, whatever the cervical ripening method, the cervix remains unchanged after 24 hours. The management of these women is not consensual and depends on the maternity unit where women are cared for. This study seeks to identify the most appropriate strategy for the management of women with an unfavorable cervix after 24 hours of cervical ripening, a strategy which would be associated with the lowest maternal and perinatal morbidity but also with the best maternal satisfaction. Because both strategies are practiced in France, the trial would compare: induction of labor with oxytocin and repeated cervical ripening. The aim is to show that repeating cervical ripening is an unnecessary procedure. And more specifically that oxytocin administration is not associated with a higher caesarean delivery rate and that it reduces the time to delivery in comparison with cervical ripening with prostaglandins.
Conditions
- Cervical Ripening
- Unfavorable Cervix
Interventions
ProstaglandinsDrug
Second cervical ripening lasting a maximum of 24 hours
OxytocinDrug
Induction of labor with oxytocin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cesarean delivery rateTime frame: Up to 2 days after intervention
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Gynaecology-obstetrics, University Hospital, Angers
Angers, France · Recruiting
Gynaecology-obstetrics, University Hospital, Bordeaux
Bordeaux, France · Terminated
Gynaecology-obstetrics, University Hospital, Brest
Brest, France · Recruiting
Gynaecology-obstetrics, University Hospital, Clermont-Ferrand
Clermont-Ferrand, France · Terminated
Gynaecology-obstetrics, Hospital St Joseph, Marseille
Marseille, France · Terminated
Gynaecology-obstetrics, University Hospital, Nancy
Nancy, France · Recruiting
Gynaecology-obstetrics, University Hospital, Nantes
Nantes, France · Recruiting
Gynaecology-obstetrics, University Hospital, Orléans
Orléans, France · Recruiting
Gynaecology-obstetrics, Port Royal Maternity Hospital, Paris
Paris, France · Recruiting
Gynaecology-obstetrics, University Hospital, Poitiers
Poitiers, France · Terminated
Gynaecology-obstetrics, Hospital, Pontoise
Pontoise, France · Not yet recruiting
Gynaecology-obstetrics, University Hospital, Saint Etienne
Saint-Etienne, France · Recruiting
Gynaecology-obstetrics, University Hospital, Strasbourg
Strasbourg, France · Not yet recruiting
Gynaecology-obstetrics, University Hospital, Tours
Tours, France · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.